It is our Malus Pumila titrated at 50% in phloridzin, ideal for modulating peak glycaemic levels thanks to this molecule’s ability to compete with the glucose transporter.

Equigluc® is supported by bioaccessibility studies using simulated in vitro static digestion, evaluating the residual phloridzin concentration after each digestion step by HPLC-DAD analysis. These studies were carried out in collaboration with the Department of Pharmacology of the University of Pavia.

FOR MORE INFORMATION